International Pharma and Healthcare Administration
International Pharma and Healthcare Administration

Length

4 months

Language

English

Online

19 Oct '21

Fee

5.900 € + V.A.T.

Evening/Weekend

Schedule

The Programme equips participants with the know-how necessary to manage most relevant ethical, economical and organizational challenges of the evolution of healthcare.
International Pharma and Healthcare Administration
International Pharma and Healthcare Administration

Length

4 months

Language

English

Fee

5,900 € + V.A.T.

Overview

The increasing costs of healthcare are jeopardising national finances, both directly and indirectly, in all developed countries around the world. A higher level of healthcare coordination and possibly even centralization is becoming necessary to achieve more effective policies, plans and investments, not only for the prevention and cure of diseases but also to preserve the economy worldwide. The development and management of healthcare ecosystems which go beyond national boundaries will be a future in the coming years and will requires executives capable of actively and adequately interacting with this new reality right from the early stages of its development.

Objectives

To provide participants with an overview of how healthcare ecosystems are evolving worldwide and focus on the challenges that the sector is facing in Europe, with a focus on quality, regulatory constraints that are more directly affecting the choices of pharma and biomedical companies in R&D, marketing, market access and governmental affairs, as well as the development of healthcare services by other organizations in the coming years.

Identify and introduce clinical and non-clinical institutional players with whom both public and private organizations can cooperate more fruitfully and closely, for the development of healthcare approaches that best respond to the upcoming challenges, while respecting the increasingly higher standards of care and demand for sustainable solutions.

Equip participants with the know-how necessary to manage the most important ethical, economic and organisational challenges accompanying the above-mentioned evolution of healthcare.

Target Audience

C-Suite Members/Candidates of Pharma and Biomedical Companies: General Managers, Heads of Business Units, Business Development, Strategic Marketing, Market Access, Governmental Affairs, Patient Advocacy Leaders and executives with leadership roles within Healthcare Service Organisations.

Certificate of Participation

At the end of the programme a certificate of participation will be issued to those who have attended at least 80% of the training activities envisioned by the programme.